Glenview, Illinois Clinical Trials

A listing of Glenview, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 114 clinical trials
iCLAS for Persistent Atrial Fibrillation

Clinical study to evaluate the safety and efficacy of the Adagio AF Cryoablation System (iCLAS) in the ablation treatment of symptomatic, persistent atrial fibrillation (PsAF). Data will be used to support a pre-market application (PMA)

persistent atrial fibrillation
Northwestern University
 (7.1 away) Contact site
  • 26 Sep, 2021
  • +16 other locations
Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. This study will evaluate how well risankizumab works compared to ustekinumab. This study will assess change in Crohn's Disease Activity Index (CDAI). Risankizumab is an investigational drug being developed for the treatment of …

tumour necrosis
abdominal pain
tumor necrosis factor
NorthShore University HealthSystem - Evanston Hospital /ID# 223538
 (6.7 away) Contact site
  • 26 Sep, 2021
  • +483 other locations
A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

This study is done to see if semaglutide has an effect on walking ability compared with placebo (dummy medicine) in people with peripheral arterial disease (PAD) and type 2 diabetes. Participants will either get semaglutide or placebo ("dummy") medicine - which treatment participants get is decided by chance. Semaglutide is …

intermittent claudication
Novo Nordisk Investigational Site
 (6.7 away) Contact site
  • 25 Sep, 2021
  • +111 other locations
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

The primary objectives of this study are to evaluate the safety and efficacy of filgotinib during induction and maintenance treatment of moderately to severely active Crohn's disease (CD) in participants who are biologic-naive and biologic-experienced. Participants who complete the study, or do not meet protocol response or remission criteria at …

maintenance treatment
Illinois Gastroenterology Group
 (8.4 away) Contact site
  • 26 Sep, 2021
  • +555 other locations
Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes

This study compares three doses of once daily semaglutide tablets in people with type 2 diabetes who were previously treated with other oral anti-diabetic medicines. Participants will be initiated on the lowest starting dose of 3 mg and gradually increased until they reach the final trial dose of 14 mg, …

Novo Nordisk Investigational Site
 (6.7 away) Contact site
  • 19 Sep, 2021
  • +155 other locations
Trilaciclib a CDK 4/6 Inhibitor in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):

This is a randomized, double-blind, placebo-controlled, global, multicenter, Phase 3 trial evaluating the impact of trilaciclib on myelopreservation and anti-tumor efficacy when administered prior to FOLFOXIRI/bevacizumab in patients with pMMR/MSS mCRC who have not received systemic therapy for metastatic disease.

Illinois Cancer Specialists
 (8.4 away) Contact site
  • 24 Sep, 2021
  • +130 other locations
A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

The purpose of this study is to assess the efficacy of seltorexant compared with quetiapine extended-release (XR) as adjunctive therapy to an antidepressant drug in treatment response in participants with major depressive disorder with insomnia symptoms (MDDIS) who have had an inadequate response to current antidepressant therapy with a selective …

depressive episode
Chicago Research Center
 (9.0 away) Contact site
  • 27 Sep, 2021
  • +180 other locations
A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression

This clinical trial will study brentuximab vedotin with CHP to find out if the drugs work for people who have certain types of peripheral T-cell lymphoma (PTCL). It will also find out what side effects occur when brentuximab vedotin and CHP are used together. A side effect is anything the …

t-cell leukemia
measurable disease
peripheral t-cell lymphoma
Illinois Cancer Specialists / Advocate Lutheran General Hospital
 (3.0 away) Contact site
  • 15 Sep, 2021
  • +30 other locations
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection

This study will evaluate whether EVO100 vaginal gel prevents the sexual transmission of CT and GC infection

tubal ligation
computed tomography
Research Network America
 (5.8 away) Contact site
  • 26 Sep, 2021
  • +94 other locations
A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

A phase 2 randomized, double blind, placebo controlled study evaluating the efficacy and safety of AL002 in participants with Early Alzheimer's Disease.

mini-mental state examination
alzheimer's disease
AMITA Health Clinical Research Institute
 (9.0 away) Contact site
  • 22 Sep, 2021
  • +85 other locations